ALTHOUGH IT'S ONLY SPRINGTIME, THE LEVEL OF ATTENTION THAT HAS BEEN paid to pharmacists and pharmacy-related issues in the national media and among the political classes in 2012 already appears unprecedented. Leading news stories have included: • Drug shortages and the developments surrounding the Sandoz manufacturing plant • Replacement of Oxycontin with OxyNEO • Expansion of scope of practice in Alberta, and recommendations to increase scope of practice for pharmacists in the Drummond report in Ontario • The 2012 Federal Budget exempting nondispensing pharmacist services from the GST/HST • Provincial premiers looking to work with health practitioners to change scope of practice These and other pharmacy-related topics have certainly been in the headlines already this year. What these developments would appear to suggest is that pharmacy is increasing its role and its mandate as an authoritative voice on issues and public policies affecting the health of Canadians. Looking at the role of pharmacy in a few recent national issues illustrates the growing infl uence that pharmacists are having on the national discourse:
Drug shortages: With the production suspension of the Sandoz plant in Boucherville in February 2012, the issue of drug shortages has become national news. An emergency debate was held in the House of Commons, MPs voted unanimously on a motion to address shortages, the House of Commons Health Committee held hearings and provincial governments reacted quickly. In the midst of this, tangible outcomes were realized. HealthPro, one of Canada's largest group purchasing organizations, announced it would no longer sole-source hospital products -sole-sourcing having been one of the causes of shortages. The pharmaceutical industry committed $200,000 towards the development of a national drug shortages reporting system. The House of Commons voted to develop a national strategy to address shortages. Health Canada began to take a more proactive approach to source alternative drugs for those impacted by the Sandoz shutdown. For over a year, CPhA has taken the lead to ensure that drug shortages remained a top-of-mind issue for politicians and industry -our efforts, both publicly and behind the scenes, to provide greater information to pharmacists about shortages, and to accelerate efforts to directly address shortages, are now paying off.
2012 Federal Budget: The March 29 Federal Budget did not contain many announcements regarding health care. However, one announcement of note was that the federal government will amend the Excise Tax to include pharmacists as health care practitioners, thereby making all non-dispensing service fees GST/ HST-exempt. This was a change long advocated for by CPhA. This amendment not only refl ects the growing importance of pharmacists as true health care practitioners, but will help to make pharmacist services more accessible for patients by removing the additional GST/HST burden.
The role of pharmacists in health care reform: In January 2012, provincial premiers announced a new Task Force on Innovation whose objective would be to recommend, by July 2012, a harmonized, pan-Canadian approach in 3 areas: scope of practice, clinical practice guidelines and health human resources. Since that time, the Task Force has focused the scope of work in these 3 areas; however, they have also made it clear that this process, while new, may well be replicated in the future to lead to greater reforms in the health system. Although this process has remained largely out of the public spotlight, CPhA has worked very closely with our colleagues at the Canadian Medical Association and Canadian Nurses Association to infl uence and steer the agenda to ensure that the role of pharmacists and their issues of concern in this process are respected and heard.
These are just 3 examples of the increasing infl uence that CPhA specifi cally, and pharmacists in general, are having on key public policy issues at the national level. And when one looks at pharmacists in provincial issues and changes, that infl uence is magnifi ed. It is true that the positions being advocated by pharmacists are not always adopted, nor are advocacy efforts always fully successful -elimination of professional allowances is perhaps the most obvious example of this. But the point is that pharmacists are, at a minimum, being heard in a way that they have not been before. This is the ultimate measure of success in advocacy, and refl ects the vision delineated in the Blueprint for Pharmacy. It is a role that we hope pharmacists will continue to play with conviction and passion.  
